https://www.benzinga.com/quote/OKYO/news
Latest OKYO Pharma Stock News | NASDAQ:OKYO | Benzinga
Get the latest news on OKYO Pharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on OKYO performance
stock newslatestokyopharmanasdaq
https://www.globenewswire.com/fr/news-release/2025/05/19/3083886/0/en/OKYO-Pharma-to-Present-at-the-GPCRs-Targeted-Drug-Discovery-Summit.html
OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery
LONDON and NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...
okyopharmapresentgpcrstargeted
https://www.biospace.com/okyo-pharma-to-host-key-opinion-leader-event-to-discuss-new-and-comprehensive-data-from-phase-2-dry-eye-disease-trial
OKYO Pharma to Host Key Opinion Leader Event to Discuss New and Comprehensive Data from Phase 2 Dry...
Mar 21, 2024 - OKYO Pharma Limited announces that it will be hosting a Key Opinion Leader (KOL) event on April 9th, 2024 at 12:00 PM ET to discuss in depth the findings of...
https://www.paloaltonetworks.com/company/press/2021/palo-alto-networks-partners-with-ingram-micro-to-bring-okyo-garde-to-small-businesses
Palo Alto Networks Partners with Ingram Micro to Bring Okyo Garde to Small Businesses - Palo Alto...
Palo Alto Networks (NYSE: PANW), the global cybersecurity leader, today announced it has signed an agreement with Ingram Micro Inc., a global leader in...
palo alto networks
https://www.paloaltonetworks.com/blog/2021/10/okyo-garde-starts-shipping/
Okyo Garde Starts Shipping Today
Oct 19, 2021 - We are excited to share that Okyo Garde starts shipping today. Small business and home customers who pre-ordered will receive theirs shortly.
okyogardestartsshippingtoday
https://www.globenewswire.com/news-release/2023/08/30/2734184/0/en/OKYO-Pharma-Achieves-90-Enrollment-in-240-Patient-Phase-2-Clinical-Trial-of-OK-101-to-treat-Dry-Eye-Disease-DED.html
OKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2
Full enrollment anticipated by first week of SeptemberOKYO on schedule to release top-line data before end of 2023Phase 2 trial is designed as potential...
okyopharmaachieves90enrollment
https://www.globenewswire.com/news-release/2024/03/22/2850877/0/en/OKYO-Pharma-Announces-OK-101-Successfully-Achieved-Statistical-Significance-for-Multiple-Signs-and-Symptoms-of-Dry-Eye-Disease-including-Ocular-Pain-Relief-in-its-First-in-Human-Ph.html
OKYO Pharma Announces OK-101 Successfully Achieved
OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain...
ok 101okyopharmaannouncessuccessfully
https://www.biospace.com/press-releases/fda-grants-okyo-pharma-fast-track-designation-to-urcosimod-for-neuropathic-corneal-pain
FDA Grants OKYO Pharma Fast Track Designation to Urcosimod for Neuropathic Corneal Pain - BioSpace
https://androidadult.com/developer/okyo/
Okyo - ANDROID APK ADULT GAMES
android apkokyoadultgames
https://okyo-lounge.de/
Startseite - OKYO
startseiteokyo
https://www.home.saxo/da-dk/markets/stocks/okyo-xnas
OKYO Pharma Ltd aktie | Saxo
OKYO Pharma Ltd is a biopharmaceutical company.
okyopharmaltdaktiesaxo
https://www.globenewswire.com/news-release/2026/03/19/3259288/0/en/OKYO-Pharma-Announces-Chairman-and-Founder-Acquires-Shares.html
OKYO Pharma Announces Chairman and Founder Acquires Shares
LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...
okyopharmaannounceschairmanfounder
https://okyo.eu/
Okyo - the ophthalmology video archive - Okyo
okyoophthalmologyvideoarchive
https://www.biospace.com/okyo-pharma-announces-filing-of-an-investigational-new-drug-ind-application-for-ok-101-to-treat-neuropathic-corneal-pain-ncp
OKYO Pharma Announces Filing of an Investigational New Drug (IND) Application for OK-101 to Treat...
Oct 9, 2023 - OKYO Pharma Limited (NASDAQ: OKYO) today announced that it filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA)...
https://www.biospace.com/okyo-pharma-participates-in-h-c-wainwright-4th-annual-ophthalmology-virtual-conference
OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - BioSpace
https://www.biospace.com/okyo-pharma-limited-okyo-or-the-company-issue-of-equity
OKYO Pharma Limited ("OKYO" or the "Company") - Issue of Equity - BioSpace
Mar 1, 2021 - OKYO Pharma Limited announces that it has issued 250,000 ordinary shares of no par value, credited as fully paid, at a price of 4.5p per share on the exercise...
issue of equitythe companyokyopharmalimited
https://www.happycow.net/reviews/okyo-balingen-456205
Okyo - Balingen Restaurant - HappyCow
okyobalingenrestauranthappycow